| Document |
Document Title |
|
WO/1996/034611A1 |
Disclosed are methods for inhibiting late radiation-induced skin damage during treatment of a patient with ionizing radiation by application of a layer of biocompatible polymer to the skin surface prior to exposure of the surface to ioni...
|
|
WO/1996/034610A1 |
Disclosed are methods for inhibiting acute radiation-induced skin damage during treatment of a patient with ionizing radiation by application of a layer of biocompatible polymer to the skin surface prior to exposure of the surface to ion...
|
|
WO/1996/032970A1 |
A method of treating a medical implant having an exposed metallic, metal oxide or ceramic surface to enhance the adhering of acrylate cement thereto. The treatment includes coating at least a portion of the exposed surface with an alkoxy...
|
|
WO/1996/031220A1 |
The present invention provides polyanionic, substituted CDs having cellular growth modulating activity. The invention further provides CDs having anionic groups on one side of the CD molecule. Therapeutic methods for using as well as met...
|
|
WO/1996/028476A1 |
A process for the production of 'beta'-(1,3)(1,6) glucan from a glucan containing cellular source is described, together with compositions and uses/methods of treatment involving glucan. The process of the invention comprises the steps o...
|
|
WO/1996/017633A1 |
This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented, for example, with one or more of the following: growth factors, ...
|
|
WO/1996/016983A1 |
The present invention provides compositions and methods for promoting cell migration and tissue regeneration. The composition contains a ligand for the 'alpha'v'beta'3 integrin and a ligand for the insulin receptor, the PDGF receptor, th...
|
|
WO/1996/015171A1 |
A new polyurethane is prepared by reacting a diol component and an organic diisocyanate with critical selection of the amount of water in the reaction mixture and the diol component. The diol component is a long chain polyoxyethylene gly...
|
|
WO/1996/013285A1 |
A dehydrated hydrogel incorporating a plasticiser and fibres which have provided cations for cross-linking the dehydrated hydrogel.
|
|
WO/1996/013284A1 |
A composition for use in treating a wound, e.g. cavity wounds, comprises a hydrogel containing O-carboxymethyl chitosan or N,O-carboxymethyl chitosan and a plasticising compound.
|
|
WO/1996/010428A1 |
The current invention is a biomedical implant comprising a biomedical matrix material and a biodegradable porosifying agent. As the porosifying agent degrades in situ, an implant with an interconnecting network is formed. The resultant m...
|
|
WO/1996/010374A1 |
The current invention is a biomedical implant comprising a biomedical matrix material and a biodegradable porosifying agent. As the porosifying agent degrades in situ, an implant with an inter-connecting network is formed. The resultant ...
|
|
WO/1996/007472A1 |
Methods and apparatus are set forth for preparing and delivering bone cement formed by combining a powdered polymer component and a liquid monomer component. The powdered polymer component is stored in an evacuated mixing chamber (102). ...
|
|
WO/1996/004025A1 |
A gel wound dressing which comprises a water absorbent copolymer of a starch and a monounsaturated carboxylic acid or an ester or salt thereof, and water. Preferably, the particles of the copolymer are small, such that at least about 70 ...
|
|
WO/1996/003160A1 |
A method for creating new tissue is described wherein cells are suspended in cryoprecipitate or fibrinogen (jointly referred to herein as "fibrinogen") which is clotted by exposure to thrombin or other serine esterase. In the preferred e...
|
|
WO/1996/002276A2 |
A cross-linked, responsive polymer gel network comprising polymer chains interconnected by way of a multifunctional cross-linker is described. The polymer chains and cross-linker have a known acceptable toxicological profile (KATP). Path...
|
|
WO/1996/002283A1 |
Alginate fibres for use in the absorption of proteinaceous material from a wound environment, said fibres absorbing the proteinaceous material into the structure of the fibres.
|
|
WO/1996/002571A1 |
The present invention relates to a fibrinogen concentrate which is characterized in that it is free of viral contaminants and in that its purity is higher than 95 %. The present invention also relates to the process for obtaining such fi...
|
|
WO/1996/002260A1 |
The use of chitosan in combination with a first polysaccharide selected from heparin, heparan sulphate and dextran sulphate for the manufacture of an agent that accelerates, stimulates and/or promotes healing of dermal wounds, said polys...
|
|
WO/1995/031223A1 |
A medical polymer gel comprising a water-swellable polymer gel and a drug immobilized thereon through a spacer and a degradable group capable of undergoing main chain breakage by an enzymatic reaction; and a water-swellable polymer gel p...
|
|
WO/1995/028124A2 |
A medical device which is a surgically implantable device coated with an adjunctive polymer system. The adjunctive polymer system forms a solid matrix when introduced into a human or animal body. The adjunctive polymer system can contain...
|
|
WO/1995/022998A1 |
A cyanoacrylate adhesive is applied onto surface skin areas prone to ulceration or irritation so as to inhibit irritation of the surface skin due to contact with an artificial device such as prosthetic devices, bandages, casts, etc.
|
|
WO/1995/023167A1 |
The present invention relates to a process of making a concentrate of coagulation proteins starting with whole human or animal plasma. This concentrate is used as a biological adhesive when extemporaneously mixed to thrombin. The concent...
|
|
WO/1995/020634A1 |
A polymerized microemulsion pressure sensitive adhesive composition is described. The composition preferably has a bicontinuous structure of a continuous phase of a hydrophobic pressure sensitive adhesive polymer and a continuous phase o...
|
|
WO/1995/017166A1 |
The present invention relates to a preserved, yet non-cytotoxic alginate based hydrating gel system for the purpose of treating wounds that need moisture. Sodium carboxymethylcellulose and an alginate polymer blend impart sufficient visc...
|
|
WO/1995/012371A1 |
A hemostatic patch that is advantageously safe and inexpensive is created that comprises a biodegradable matrix such as an absorbable gelating sponge, and an effective amount of epsilon aminocaproic acid for inhibiting fibrinolysis. Epsi...
|
|
WO/1995/009658A1 |
A wound dressing which comprises alginate characterised in that the alginate has a mannuronate content of 50 % to 80 %, has a molecular weight of 7000 to 40000 and has a monovalent : polyvalent ion content of from 10 to 30 : 70 to 90.
|
|
WO/1995/008984A1 |
An aerosol composition for forming a preferably hydrated membrane after vaporizing comprises at least one hydrophobic phase containing at least one film-forming polymer at least partly solubilized in an organic solvent system and selecte...
|
|
WO/1995/007719A1 |
A wound covering material containing at least macromolecules having a sol-gel transition point in an aqueous solution; substantially displaying a water-insolubility at a temperature higher than the sol-gel transition point; and reversibl...
|
|
WO/1995/004772A1 |
Method for the preparation of polyaminoacids, with controlled molecular weights, by polymerization of the N-carboxyanhydrides (NCA) of at least one amino acid, using at least one strong base initiator in a liquid medium. The invention is...
|
|
WO/1995/003786A2 |
Provided is a pharmaceutical composition, comprising a pharmaceutically effective amount of an acidic polysaccharide and/or a derivative thereof, a gaseous vehicle, and a pharmaceutically acceptable carrier or excipient. Said acidic poly...
|
|
WO/1995/003838A1 |
The present invention is directed to a topical composition for the treatment of psoriasis. The composition comprises a film forming agent, a plasticizer, an aqueous alcoholic solution and an amount of alkali effective to prevent the gell...
|
|
WO/1995/000184A1 |
A therapeutic medical device is described that is comprised of a dried hydrogel of a hydrophilic-hygroscopic polymer, such as an unmodified or modified polymeric carbohydrate, in the form of a solid foam. The dried hydrogel is prepared b...
|
|
WO/1995/000153A1 |
A cyanoacrylate adhesive is applied onto intact surface skin areas prone to ulceration so as to inhibit formation of surface skin ulcers.
|
|
WO/1994/025590A2 |
The nucleic acid and amino acid sequences of a pair of human proteins, trichohyalin (figure 3) and transglutaminase-3 (figures 11A and 11B), in addition to the sequence of mouse transglutaminase-3 (also figures 11A and 11B), have been di...
|
|
WO/1994/022470A1 |
A dermal preparation for treatment of skin wounds containing as an active ingredient human blood coagulation factor XIII. This preparation may further contain aprotinin. The dermal preparation, when applied to damaged skin, especially bu...
|
|
WO/1994/022503A1 |
A fibrin glue comprising a component A which comprises a cryoprecipitate of whole blood and a sufficient amount of tranexamic acid 4-(aminomethyl)cyclohexane carboxylic acid or its pharmaceutically acceptable salts and, a component B com...
|
|
WO/1994/022504A1 |
A disinfectant film-forming wound-covering gel promotes the healing of wounds, in particular in reptiles. The gel consists of buffered PVP/VA-copolymers combined with quaternary ammonium salts.
|
|
WO/1994/020133A1 |
This invention provides supplemented and unsupplemented tissue sealants (TSs), such as fibrin glue, as well as methods of their production and use. In one embodiment, this invention provides TSs that do not inhibit full thickness skin wo...
|
|
WO/1994/017839A1 |
A method for improving the size and appearance of a scar associated with a fibromatosis, a keloid, or a hypertrophic wound healing disorder comprises stimulating collagenase activity in the scar. Preferably, stimulating collagenase activ...
|
|
WO/1994/016746A1 |
A wound dressing is characterised in that the wound-contacting surface thereof comprises carboxymethyl cellulose filaments capable of absorbing at least 15 times their own weight of 0.9 % by weight aqueous saline solution (as measured by...
|
|
WO/1994/016951A1 |
A method and apparatus for packaging, mixing and delivering bone cement. The apparatus may include a bone cement gun (100) having a flexible container (52) which is able to store at least two components of the bone cement. In this regard...
|
|
WO/1994/013333A1 |
A wound dressing comprises a chemically modified polymer which has a free radical activity in the DPPH Test in the range 15-80 percent. It may comprise a chemically modified polymer which carries at least one chemical group which is a pe...
|
|
WO/1994/013334A1 |
Metallic surgical implant materials having improved strength of connection with bone are produced when the implants are treated prior to implantation with an aqueous solution of sodium fluoride.
|
|
WO/1994/012128A1 |
The invention provides a drainage bag (e.g. an ostomy bag or the like) for receiving bodily waste, the drainage bag comprising a water-impermeable outer bag (1); a water-impermeable inner bag (2) enclosed therein; and means (3, 4) defini...
|
|
WO/1994/008635A1 |
A polymer implant material primarily for use as a biodegradable barrier film for the prevention of post-surgical adhesions comprises a substantially continuous polymeric film, which is biodegradable in vivo; has at least one surface whic...
|
|
WO/1994/007548A1 |
A method for preparing a biological adhesive involves preparing and collecting a cryoprecipitate, constituting said adhesive, from a frozen plasma and is characterized in that the initial plasma used is a platelet-enriched plasma. This m...
|
|
WO/1994/007420A1 |
An applicator for spraying tissue adhesive onto an affected portion comprises: a sterilized gas supply chamber; a sterilized gas supply pipe connected to the sterilized gas supply chamber; two sterilized gas injection nozzles for injecti...
|
|
WO/1994/006484A1 |
The wound protecting dressing comprises chitosan as base material. The chitosan is microcrystalline chitosan in a gel dispersion form in a composition where the carrier liquid is volatile at body temperature of a human or animal, the mic...
|
|
WO/1994/006296A1 |
The present invention relates to iodine demand disinfectants. It relates in particular to a process for preparing a polyiodide-resin for use as a iodine demand disinfectant wherein a porous strong base anion exchange resin in a salt form...
|
